CJC-1295
A growth hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
View Protocol →Growth-hormone secretagogues and GHRH analogs studied for sustained GH and IGF-1 elevation, recovery, and body composition, from the classic GHRH + GHRP pairing to standalone oral secretagogues. For research purposes only.
A growth hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
View Protocol →A selective growth hormone secretagogue researched for GH release with a clean side-effect profile.
View Protocol →A GHRH analog studied for stimulating the body's natural growth hormone production.
View Protocol →A potent GHRH analogue (brand EGRIFTA) studied particularly for visceral fat reduction.
View Protocol →An orally active GH secretagogue with a ~24-hour half-life, studied for sustained GH and IGF-1 elevation.
View Protocol →For research and educational purposes only. This information is not medical advice.